Shimotake Takashi, Aoi Shigeyoshi, Tomiyama Hideki, Iwai Naomi
Division of Surgery, Children's Research Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan.
J Pediatr Surg. 2003 May;38(5):694-7. doi: 10.1016/jpsu.2003.50185.
BACKGROUND/PURPOSE: Recent studies have found that anomalous pancreaticobiliary ductal union (APBDU) is a substantial risk factor for biliary tract cancer at a younger age. DPC-4 (Smad-4) is a new tumor suppressor gene frequently inactivated in pancreatic and bile duct adenocarcinoma. To clarify carcinogenesis in APBDU, the authors investigated possible DPC-4 and K-ras mutations in 35 pediatric patients.
DNA was extracted from biliary tract epithelial cells, which were resected surgically and histologically purified using microdissection. Polymerase chain reaction (PCR) primers were designed specifically for exons 8-11 of DPC-4 (18q21.1) and exons 1-2 of the K-ras oncogene (12p12.1). DNA sequences were determined using the direct DyeDeoxy Terminator Cycle method.
Of 35 children, 30 had wild-type DPC-4 and K-ras genes. K-ras mutations were detected in 5 patients, 4 of whom showed epithelial hyperplasia or metaplasia. In a 12-year-old girl with adenocarcinoma arising from a choledochal cyst, K-ras and DPC-4 (homozygous deletion) mutations were identified simultaneously.
These results suggest that carcinogenesis in the biliary tract epithelium in APBDU is accompanied by multistep genetic mutational events; K-ras gene mutation occurs early in epithelial hyperplasia or metaplasia, whereas inactivation of the DPC-4 gene accumulates late in the progression of biliary tract adenocarcinoma.
背景/目的:近期研究发现,胰胆管汇合异常(APBDU)是导致较年轻患者发生胆管癌的一个重要危险因素。DPC-4(Smad-4)是一种新的肿瘤抑制基因,在胰腺癌和胆管腺癌中常发生失活。为阐明APBDU中的致癌机制,作者对35例儿科患者进行了DPC-4和K-ras基因突变的研究。
从手术切除的胆管上皮细胞中提取DNA,并通过显微切割进行组织学纯化。针对DPC-4(18q21.1)的第8至11外显子和K-ras癌基因(12p12.1)的第1至2外显子设计了聚合酶链反应(PCR)引物。采用直接染料脱氧终止循环法测定DNA序列。
35例患儿中,30例DPC-4和K-ras基因呈野生型。5例患者检测到K-ras基因突变,其中4例表现为上皮增生或化生。在一名因胆总管囊肿发生腺癌的12岁女孩中,同时检测到K-ras和DPC-4(纯合缺失)突变。
这些结果表明,APBDU中胆管上皮的致癌过程伴随着多步骤的基因突变事件;K-ras基因突变发生在上皮增生或化生的早期,而DPC-4基因的失活在胆管腺癌进展的后期累积。